COVID-19 Treatment: WuXi Biologics, Vir Biotechnology collaborate for Global Development of antibodies Medical Dialogues Bureau27 Feb 2020 3:30 AM GMTWuXi Biologics will conduct cell-line development, process and formulation development, if the antibodies receive regulatory approvals, WuXi Biologics...
WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader Medical Dialogues Bureau20 Feb 2020 3:45 AM GMTShanghai: WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...